Related Experiment Video
Updated: Jul 14, 2026
08:47
Spectral Confocal Imaging of Fluorescently tagged Nicotinic Receptors in Knock-in Mice with Chronic Nicotine Administration
Published on: February 10, 2012
Caffeine's influence on nicotine's effects in nonsmokers
Melissa D Blank1, Bethea A Kleykamp, Janine M Jennings
1Virginia Commonwealth University, Department of Psychology, Richmond, VA 23298-0205, USA. blankmd@vcu.edu
American Journal of Health Behavior
|June 9, 2007
Summary
Caffeine does not alter nicotine's impact on heart rate or reaction time in nonsmokers. Moderate caffeine doses showed no influence on the physiological and subjective effects of nicotine.
Area of Science:
- Pharmacology
- Neuroscience
- Human Physiology
Background:
- Nicotine and caffeine are widely consumed psychoactive substances.
- Understanding their interactions is crucial for public health.
- Previous research on interactions has yielded mixed results.
Purpose of the Study:
- To investigate the influence of moderate caffeine doses on nicotine's effects.
- To assess nicotine's impact on physiological and subjective measures in individuals consuming moderate caffeine.
Main Methods:
- Double-blind, randomized controlled trial with 20 healthy, non-smoking participants.
- Administration of varying doses of caffeine (0, 75, 150 mg) and nicotine (2, 4 mg).
- Measurement of heart rate, reaction time, and subjective ratings across four sessions.
Main Results:
- Nicotine administration led to increased heart rate and aversive subjective effects.
- Nicotine use resulted in decreased reaction times.
- These nicotine-induced changes were not significantly affected by the different caffeine doses administered.
Conclusions:
- Moderate doses of caffeine do not appear to modulate the physiological or subjective effects of nicotine in non-smoking individuals.
- The findings suggest independent action of nicotine and moderate caffeine levels on key physiological and perceptual measures.
Related Concept Videos
01:23Drugs Acting on Autonomic Ganglia: Stimulants
Ganglionic stimulants activate NM nicotinic receptors in autonomic ganglia, falling into two categories: nicotine mimetics [e.g., lobeline, dimethylpiperazine, tetramethylammonium] and muscarinic receptor agonists [e.g., muscarine, methacholine]. The first category's action is rapid and blocked by nicotinic receptor antagonists, while the second category's action is delayed and blocked by atropine-like agents. Nicotine, an alkaloid, affects the heart rate by stimulating sympathetic or...
01:27CNS Depressants: Alcohol and Nicotine
Ethanol, a clear colorless alcohol, has been consumed by humans for millennia, but its effects on the body are far from benign. At lower doses, it induces decreased inhibitions and loquaciousness, leading to its social appeal. However, it can cause severe consequences at higher doses, such as coma and respiratory depression, due to its zero-order elimination kinetics. Chronic ethanol abuse wreaks havoc on multiple organ systems, particularly the CNS and the liver. Abrupt cessation of ethanol...
01:29Stimulants
Stimulants are substances that enhance neural activity and elevate dopamine levels in the brain, leading to their highly addictive nature. These drugs include cocaine, amphetamines, MDMA, caffeine, and nicotine, each with distinct mechanisms of action and varied health implications.
Cocaine can be administered via snorting, injection, or smoking. It primarily functions by blocking the reuptake of dopamine, resulting in a euphoric high characterized by an intense sensation of happiness and...
Cocaine can be administered via snorting, injection, or smoking. It primarily functions by blocking the reuptake of dopamine, resulting in a euphoric high characterized by an intense sensation of happiness and...
01:24CNS Stimulants: Cocaine, Amphetamines and Cannabinoids
CNS stimulants, such as cocaine, amphetamines, and cannabinoids, have varying structures and mechanisms of action that lead to different therapeutic effects and side effects. Cocaine, with its molecular formula C17H21NO4, is a tropane alkaloid and a tertiary amino compound. It has two chemical forms: the hydrochloride salt and the "freebase." The former is in powder form, while the latter involves removing the hydrochloride salt to create a form that can be smoked. Cocaine exerts its effects by...
01:21Drugs Affecting Neurotransmitter Release or Uptake
Certain drugs can affect how neurotransmitters called catecholamines, are released or taken back up in the adrenergic neuron. They can have different effects on the body's sympathetic transmission. Reserpine, a natural compound found in the Rauwolfia shrub, blocks a transporter called vesicular monoamine transporter (VMAT), which leads to a buildup of catecholamines in the cell and reduces sympathetic transmission. Another drug called guanethidine works in multiple ways, including blocking...
01:25Adrenergic Agonists: Indirect-Acting Agents
Indirect-acting adrenergic agonists potentiate the effects of endogenous catecholamines through different mechanisms without directly binding to adrenoceptors.
One mechanism involves depleting stored catecholamines by displacing them from synaptic vesicles. These agents, known as "displacers," are transported into vesicles at the expense of noradrenaline. Examples include amphetamine and tyramine, which lack a catechol moiety, resulting in prolonged action, improved oral bioavailability, and...
One mechanism involves depleting stored catecholamines by displacing them from synaptic vesicles. These agents, known as "displacers," are transported into vesicles at the expense of noradrenaline. Examples include amphetamine and tyramine, which lack a catechol moiety, resulting in prolonged action, improved oral bioavailability, and...